Intravenous Infusion Pump Market Forecasted to Reach USD 9.7 Billion by 2032 (1)

1
Intravenous Infusion Pump Market Forecasted to
Reach USD 9.7 Billion by 2032
2

• Industry Insights

• Intravenous Infusion Pumps Market is anticipated
  to grow considerably during 2023-2032 owing to
  the increasing product demand in home care
  settings to limit hospital expenses. Constant
  technological innovations in intravenous infusion
  pumps, such as smart infusion pumps, have
  resulted in the growing adoption of IV infusion
  pumps in a homecare setting. Besides, patients
  with cancer, neurological disorders, and
  diabetes, among other conditions, require
  long-term care and high cost associated with
  hospital-based infusion therapy, which would
  positively influence market expansion over the
  ensuing years.
• Overall, the intravenous infusion industry is
  segmented in terms of product, application,
  end-use, and region.
• Based on product, the volumetric segment is
  anticipated to grow considerably through 2032 due
  to the product's ability to deliver specific
  number of fluids at a cost-effective rate.
  Moreover, the wide application of volumetric
  pumps in disease management and parenteral
  nutrition will also assist segmental growth. IV
  volumetric pumps also enable precise and
  controlled delivery of fluids, medications, and
  nutrients into a patient's bloodstream. It also
  ensures that the correct dose is delivered to the
  patients, reducing the risk of complications
  compared to manual administration.

3

• By application, the oncology segment accounted
  for over 9 market share in 2022. IV infusion
  pumps are increasingly used to administer
  chemotherapy and other intravenous medications to
  cancer patients. As per the American Cancer
  Society projections, it was reported that the
  year 2022 witnessed more than 1.5 million new
  cancer cases and about 609,360 fatalities. In
  addition, these pumps also help administer
  chemotherapy drugs in a precise and controlled
  manner to avoid toxicity and other side effects.
• Considering the end-use, the homecare segment is
  slated to be valued at over USD 2.5 billion by
  2032. Increasing prominence of several benefits
  the pumps offer to patients requiring continued
  care after discharge, coupled with the adoption
  of smart, portable IV infusion pumps, will fuel
  the homecare segment growth. Additionally,
  mounting use of an IV infusion pump at home, in
  place of hospitals, proves out to be more
  economical, especially when hospitalizing
  patients is not necessary.

4

• Regional Analysis

From the regional perspective, the Europe
intravenous infusion pump market will exhibit
lucrative growth during the estimated timeline.
The regional market growth can majorly be
attributed to the rising prevalence of chronic
diseases and the availability of technologically
advanced healthcare infrastructure in the region.

• Competitive Analysis

• F. Hoffmann-La Roche Ltd.
• Boston Scientific Corporation
• Fresenius Kabi
• Moog Inc.
• Terumo Corporation
• Tandem Diabetes Care, Inc.
• Micrel Medical Devices SA
• Shenzhen ENMIND Technology Co., Ltd.
• Medtronic
• ICU Medical

5
Biotechnology Instruments Market _at_
https//www.gminsights.com/industry-analysis/intra
venous-infusion-pump-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/5
528
Request for customization _at_ https//www.gminsights
.com/roc/5528
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com